Department of Hematology Oncology, Clinica Las Condes, Santiago, Chile and School of Medicine, Universidad Finis Terrae, Santiago, Chile.
Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Transplant Cell Ther. 2024 May;30(5):468-474. doi: 10.1016/j.jtct.2024.02.011. Epub 2024 Feb 10.
We provide a summary of the 4th ASTCT International Workshop with presentations from experts from Chile ("Setting Up a Transplantation Program in Chile," by Dr Pablo Ramirez), Saudi Arabia ("Developing Quality Programs in North Africa," by Dr Amal Alseraihy), and Japan ("The Japanese Transplant Registry Unified Management Program [TRUMP]: Current Issues and the Future," by Dr Yoshiko Atsuta). Workshop objectives included: (1) recognizing the benefits and importance for low- and middle-income countries of developing quality criteria and programs beyond existing accreditation programs, such as the Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Accreditation Committee ISCT-Europe and EBMT (JACIE); (2) describing the relationships among monitoring outcomes, including mortality, improvement of care, data reporting, and associated costs; and (3) reviewing how quality structures have been implemented and are improving care worldwide.
我们提供了第 4 届 ASTCT 国际研讨会的摘要，内容来自智利专家（Pablo Ramirez 博士的“在智利建立移植项目”）、沙特阿拉伯专家（Amal Alseraihy 博士的“在北非发展质量项目”）和日本专家（Yoshiko Atsuta 博士的“日本移植注册统一管理项目[TRUMP]：当前问题与未来”）的演讲。研讨会的目标包括：（1）认识到制定超越现有认证计划（如细胞治疗认证基金会[FACT]和国际细胞治疗学会-欧洲与欧洲骨髓移植学会联合认证委员会[JACIE]）的质量标准和计划对中低收入国家的益处和重要性；（2）描述监测结果（包括死亡率、改善护理、数据报告和相关成本）之间的关系；（3）审查质量结构是如何在全球范围内实施并改善护理的。
